Sort   by:  
 Page size 
UnknownHigher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownThe 2024 report of the Lancet Countdown on health and climate change: facing record-breaking threats from delayed action.
Not available
S-EPMC7616816 | biostudies-literature
UnknownThe tuatara genome reveals ancient features of amniote evolution.
Not available
S-EPMC7116210 | biostudies-literature
UnknownThe effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study.
Not available
S-EPMC3191151 | biostudies-literature
UnknownGeospatial immune variability illuminates differential evolution of lung adenocarcinoma.
Not available
S-EPMC7610840 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Not available
S-EPMC8822604 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
UnknownEpidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project.
Not available
S-EPMC6863788 | biostudies-literature
Sort   by:  
 Page size